Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis

N. Steele, Richard J. Gralla, D. W. Braun, C. W. Young

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The antiemetic effect of oral nabilone, a synthetic cannabinoid, given at a dose of 2 mg every 12 hours was compared to oral slow-release capsules of prochlorperazine given at a dose of 10 mg every 12 hours by a double-blind crossover method in 37 patients receiving cancer chemotherapy. Patients received one of the following as the primary emetic stimulus: high-dose cis-dichlorodiammineplatinum (II) (DDP), low-dose DDP, mechlorethamine, streptozotocin, actinomycin D, or DTIC. Although results varied according to strength of emetic stimulus received, both nabilone and prochlorperazine appeared to produce antiemetic effects. Eighteen of the 37 patients achieved a complete or partial elimination of symptoms: seven with nabilone alone, three with prochlorperazine alone, and eight with each drug. Nabilone appeared to be the more effective antiemetic for patients who received chemotherapy agents other than high-dose DDP; it was equivalent to prochlorperazine for those who did receive high-dose DDP. Side effects from prochlorperazine were limited to mild drowsiness occurring among 35% of the patients. The side effects from nabilone were drowsiness and dizziness which occurred frequently and were dose-limiting in 25% of patients.

Original languageEnglish (US)
Pages (from-to)219-224
Number of pages6
JournalCancer Treatment Reports
Volume64
Issue number2-3
StatePublished - 1980
Externally publishedYes

Fingerprint

Prochlorperazine
Antiemetics
Vomiting
Drug Therapy
Emetics
Sleep Stages
Mechlorethamine
Dacarbazine
Cannabinoids
Dizziness
Dactinomycin
Streptozocin
Double-Blind Method
Cisplatin
Capsules
nabilone
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. / Steele, N.; Gralla, Richard J.; Braun, D. W.; Young, C. W.

In: Cancer Treatment Reports, Vol. 64, No. 2-3, 1980, p. 219-224.

Research output: Contribution to journalArticle

Steele, N. ; Gralla, Richard J. ; Braun, D. W. ; Young, C. W. / Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. In: Cancer Treatment Reports. 1980 ; Vol. 64, No. 2-3. pp. 219-224.
@article{5e8284ccf02046a9a2e19c6233288e7d,
title = "Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis",
abstract = "The antiemetic effect of oral nabilone, a synthetic cannabinoid, given at a dose of 2 mg every 12 hours was compared to oral slow-release capsules of prochlorperazine given at a dose of 10 mg every 12 hours by a double-blind crossover method in 37 patients receiving cancer chemotherapy. Patients received one of the following as the primary emetic stimulus: high-dose cis-dichlorodiammineplatinum (II) (DDP), low-dose DDP, mechlorethamine, streptozotocin, actinomycin D, or DTIC. Although results varied according to strength of emetic stimulus received, both nabilone and prochlorperazine appeared to produce antiemetic effects. Eighteen of the 37 patients achieved a complete or partial elimination of symptoms: seven with nabilone alone, three with prochlorperazine alone, and eight with each drug. Nabilone appeared to be the more effective antiemetic for patients who received chemotherapy agents other than high-dose DDP; it was equivalent to prochlorperazine for those who did receive high-dose DDP. Side effects from prochlorperazine were limited to mild drowsiness occurring among 35{\%} of the patients. The side effects from nabilone were drowsiness and dizziness which occurred frequently and were dose-limiting in 25{\%} of patients.",
author = "N. Steele and Gralla, {Richard J.} and Braun, {D. W.} and Young, {C. W.}",
year = "1980",
language = "English (US)",
volume = "64",
pages = "219--224",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "2-3",

}

TY - JOUR

T1 - Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis

AU - Steele, N.

AU - Gralla, Richard J.

AU - Braun, D. W.

AU - Young, C. W.

PY - 1980

Y1 - 1980

N2 - The antiemetic effect of oral nabilone, a synthetic cannabinoid, given at a dose of 2 mg every 12 hours was compared to oral slow-release capsules of prochlorperazine given at a dose of 10 mg every 12 hours by a double-blind crossover method in 37 patients receiving cancer chemotherapy. Patients received one of the following as the primary emetic stimulus: high-dose cis-dichlorodiammineplatinum (II) (DDP), low-dose DDP, mechlorethamine, streptozotocin, actinomycin D, or DTIC. Although results varied according to strength of emetic stimulus received, both nabilone and prochlorperazine appeared to produce antiemetic effects. Eighteen of the 37 patients achieved a complete or partial elimination of symptoms: seven with nabilone alone, three with prochlorperazine alone, and eight with each drug. Nabilone appeared to be the more effective antiemetic for patients who received chemotherapy agents other than high-dose DDP; it was equivalent to prochlorperazine for those who did receive high-dose DDP. Side effects from prochlorperazine were limited to mild drowsiness occurring among 35% of the patients. The side effects from nabilone were drowsiness and dizziness which occurred frequently and were dose-limiting in 25% of patients.

AB - The antiemetic effect of oral nabilone, a synthetic cannabinoid, given at a dose of 2 mg every 12 hours was compared to oral slow-release capsules of prochlorperazine given at a dose of 10 mg every 12 hours by a double-blind crossover method in 37 patients receiving cancer chemotherapy. Patients received one of the following as the primary emetic stimulus: high-dose cis-dichlorodiammineplatinum (II) (DDP), low-dose DDP, mechlorethamine, streptozotocin, actinomycin D, or DTIC. Although results varied according to strength of emetic stimulus received, both nabilone and prochlorperazine appeared to produce antiemetic effects. Eighteen of the 37 patients achieved a complete or partial elimination of symptoms: seven with nabilone alone, three with prochlorperazine alone, and eight with each drug. Nabilone appeared to be the more effective antiemetic for patients who received chemotherapy agents other than high-dose DDP; it was equivalent to prochlorperazine for those who did receive high-dose DDP. Side effects from prochlorperazine were limited to mild drowsiness occurring among 35% of the patients. The side effects from nabilone were drowsiness and dizziness which occurred frequently and were dose-limiting in 25% of patients.

UR - http://www.scopus.com/inward/record.url?scp=0018899177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018899177&partnerID=8YFLogxK

M3 - Article

C2 - 6250699

AN - SCOPUS:0018899177

VL - 64

SP - 219

EP - 224

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 2-3

ER -